These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Receptor tyrosine kinase signaling: a view from quantitative proteomics. Dengjel J; Kratchmarova I; Blagoev B Mol Biosyst; 2009 Oct; 5(10):1112-21. PubMed ID: 19756300 [TBL] [Abstract][Full Text] [Related]
12. Breakdown of endocytosis in the oncogenic activation of receptor tyrosine kinases. Abella JV; Park M Am J Physiol Endocrinol Metab; 2009 May; 296(5):E973-84. PubMed ID: 19240253 [TBL] [Abstract][Full Text] [Related]
13. [Signal transduction inhibitor]. Ueda Y; Saijo N Gan To Kagaku Ryoho; 2001 May; 28(5):591-600. PubMed ID: 11383206 [TBL] [Abstract][Full Text] [Related]
14. Tyrosine phosphorylation profiling reveals the signaling network characteristics of Basal breast cancer cells. Hochgräfe F; Zhang L; O'Toole SA; Browne BC; Pinese M; Porta Cubas A; Lehrbach GM; Croucher DR; Rickwood D; Boulghourjian A; Shearer R; Nair R; Swarbrick A; Faratian D; Mullen P; Harrison DJ; Biankin AV; Sutherland RL; Raftery MJ; Daly RJ Cancer Res; 2010 Nov; 70(22):9391-401. PubMed ID: 20861192 [TBL] [Abstract][Full Text] [Related]
15. Receptor association and tyrosine phosphorylation of S6 kinases. Rebholz H; Panasyuk G; Fenton T; Nemazanyy I; Valovka T; Flajolet M; Ronnstrand L; Stephens L; West A; Gout IT FEBS J; 2006 May; 273(9):2023-36. PubMed ID: 16640565 [TBL] [Abstract][Full Text] [Related]
16. Signal transduction in cell-matrix interactions. Guan JL; Chen HC Int Rev Cytol; 1996; 168():81-121. PubMed ID: 8843649 [TBL] [Abstract][Full Text] [Related]
17. Vesicular trafficking of tyrosine kinase receptors and associated proteins in the regulation of signaling and vascular function. Mukherjee S; Tessema M; Wandinger-Ness A Circ Res; 2006 Mar; 98(6):743-56. PubMed ID: 16574915 [TBL] [Abstract][Full Text] [Related]
18. Receptor tyrosine kinases and the regulation of hematopoiesis. Paulson RF; Bernstein A Semin Immunol; 1995 Aug; 7(4):267-77. PubMed ID: 8520031 [TBL] [Abstract][Full Text] [Related]
19. New paradigms in anticancer therapy: targeting multiple signaling pathways with kinase inhibitors. Faivre S; Djelloul S; Raymond E Semin Oncol; 2006 Aug; 33(4):407-20. PubMed ID: 16890796 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of receptor tyrosine kinase-based signal transduction as specific target for cancer treatment. Roussidis AE; Karamanos NK In Vivo; 2002; 16(6):459-69. PubMed ID: 12494890 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]